Hypothesis: With advancing age, the gut microbiota exhibit reduced β‑glucosidase expression, diminishing the conversion of oral crocin to crocetin. This decline limits crocetin‑induced stabilization of HIF‑1α in intestinal enteroendocrine cells, thereby attenuating the release of gut‑derived metabolites (e.g., serotonin, short‑chain fatty acids) that normally activate vagal afferents and suppress central NF‑κB signaling. Consequently, the gut‑brain anti‑inflammatory axis weakens, contributing to inflammaging and heightened neuronal vulnerability.

Mechanistic rationale: Crocetin, after microbial deglycosylation, reaches plasma concentrations sufficient to engage HIF‑1α in gut epithelial cells (as suggested by its ability to modulate metabolomics without entering the brain) [[2]]. HIF‑1α activation in enteroendocrine cells drives a transcriptional program that increases production of anti‑inflammatory signals such as indole‑propionic acid and peptide YY, which travel via the vagus nerve to dampen microglial activation [[1]]. Age‑associated shifts in microbiota composition—particularly loss of Bacteroides and Lactobacillus strains known to harbor robust β‑glucosidase activity [[5]]—would lower crocetin yield, reducing HIF‑1α signaling and breaking this protective loop.

Testable predictions:

1. Old mice (≥20 mo) will show lower fecal β‑glucosidase activity and reduced plasma crocetin:Crocin ratios after oral crocin dosing compared with young mice (3 mo).
2. HIF‑1α protein levels in isolated intestinal enteroendocrine cells will be significantly lower in old mice following crocin gavage, while direct crocetin administration will rescue HIF‑1α stabilization to youthful levels.
3. Vagal firing rates recorded in response to crocin will be attenuated in aged animals, correlating with decreased circulating anti‑inflammatory metabolites (measured by targeted metabolomics).
4. Pharmacological inhibition of β‑glucosidase in young mice (using a specific inhibitor such as conduritol B epoxide) will recapitulate the aged phenotype: reduced crocetin conversion, diminished enteroendocrine HIF‑1α, elevated plasma IL‑6/TNF‑α, and exacerbated neuronal damage in a middle‑cerebral‑artery occlusion model.
5. Supplementation with a β‑glucosidase‑enriched probiotic cocktail (e.g., Lactobacillus plantarum engineered for high β‑glucosidase expression) will restore crocetin‑dependent HIF‑1α signaling, normalize vagal tone, and mitigate age‑related cognitive decline in senescence‑accelerated mice.

Falsifiability: If old mice exhibit unchanged fecal β‑glucosidase activity, comparable crocetin plasma ratios, or unaltered enteroendocrine HIF‑1α after crocin treatment relative to young controls, the central claim that microbial enzymatic loss drives the age‑related breakdown of the gut‑brain axis would be refuted. Similarly, if vagal signaling and anti‑inflammatory metabolite levels remain unaffected despite manipulated β‑glucosidase activity, the proposed mechanistic link to central neuroprotection would be invalidated.

This hypothesis directly ties the "messy, bidirectional mess" of the gut‑brain interface to a measurable microbial enzymatic deficit, offering a concrete entry point for interventions that target microbiota‑mediated prodrug activation to counteract inflammaging.